
Aerie Pharmace is a drug manufacturers-specialty & generic business based in the US. Aerie Pharmace shares (AERI) are listed on the NASDAQ and all prices are listed in US Dollars. Aerie Pharmace employs 376 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Aerie Pharmace
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AERI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Aerie Pharmace stock price (NASDAQ: AERI)
Use our graph to track the performance of AERI stocks over time.Aerie Pharmace shares at a glance
Latest market close | $7.50 |
---|---|
52-week range | $4.81 - $17.21 |
50-day moving average | $6.71 |
200-day moving average | $8.66 |
Wall St. target price | $18.67 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.47 |
Buy Aerie Pharmace shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Aerie Pharmace stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aerie Pharmace price performance over time
Historical closes compared with the close of $7.5 from 2022-06-30
1 week (2022-06-24) | -0.79% |
---|---|
1 month (2022-06-01) | 51.52% |
3 months (2022-03-29) | N/A |
6 months (2021-12-31) | 6.84% |
1 year (2021-07-02) | -53.15% |
---|---|
2 years (2020-07-02) | -46.31% |
3 years (2019-07-02) | 26.69 |
5 years (2017-06-30) | 52.55 |
Aerie Pharmace financials
Revenue TTM | $201 million |
---|---|
Gross profit TTM | $167.3 million |
Return on assets TTM | -7.55% |
Return on equity TTM | -2255.01% |
Profit margin | -34.2% |
Book value | $0.51 |
Market capitalisation | $364.7 million |
TTM: trailing 12 months
Aerie Pharmace share dividends
We're not expecting Aerie Pharmace to pay a dividend over the next 12 months.
Aerie Pharmace share price volatility
Over the last 12 months, Aerie Pharmace's shares have ranged in value from as little as $4.81 up to $17.21. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aerie Pharmace's is 0.7564. This would suggest that Aerie Pharmace's shares are less volatile than average (for this exchange).
Aerie Pharmace overview
Aerie Pharmaceuticals, Inc. , a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; and Rocklatan, a once-daily fixed-dose combination of Rhopressa and latanopros to reduce IOP to treat patients with open-angle glaucoma or ocular hypertension. The company also develops AR-15512 to treat signs and symptoms of dry eye; and AR-1105 and AR-14034 SR sustained-release implants focused on retinal diseases. It has a collaborative research, development, and licensing agreement with DSM Biomedical. Aerie Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Durham, North Carolina.
Frequently asked questions
What percentage of Aerie Pharmace is owned by insiders or institutions?Currently 1.841% of Aerie Pharmace shares are held by insiders and 110.342% by institutions. How many people work for Aerie Pharmace?
Latest data suggests 376 work at Aerie Pharmace. When does the fiscal year end for Aerie Pharmace?
Aerie Pharmace's fiscal year ends in December. Where is Aerie Pharmace based?
Aerie Pharmace's address is: 4301 Emperor Boulevard, Durham, NC, United States, 27703 What is Aerie Pharmace's ISIN number?
Aerie Pharmace's international securities identification number is: US00771V1089 What is Aerie Pharmace's CUSIP number?
Aerie Pharmace's Committee on Uniform Securities Identification Procedures number is: 00771V108
More guides on Finder
-
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
-
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
-
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert